Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1289084-83-8

Post Buying Request

1289084-83-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1289084-83-8 Usage

General Description

(5-Bromo-3-fluoro-pyridin-2-yl)-hydrazine is a chemical compound with the molecular formula C5H5BrFN4. It is a hydrazine derivative with a pyridine ring substituted with bromine and fluorine atoms. (5-BroMo-3-fluoro-pyridin-2-yl)-hydrazine has potential applications in pharmaceutical and chemical research due to its unique structure and properties. It may be used as a building block in the synthesis of complex organic molecules or as a reagent in chemical reactions. Further research and development may uncover additional uses and potential benefits of this chemical compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1289084-83-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,9,0,8 and 4 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1289084-83:
(9*1)+(8*2)+(7*8)+(6*9)+(5*0)+(4*8)+(3*4)+(2*8)+(1*3)=198
198 % 10 = 8
So 1289084-83-8 is a valid CAS Registry Number.

1289084-83-8Relevant articles and documents

SUBSTITUTED FUSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS

-

Page/Page column 59, (2015/11/17)

The present invention relates to substituted fused heterocyclic compounds. The substituted fused heterocyclic compounds are GPR1 19 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of substituted fused heterocyclic compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

TRIAZOLOPYRIDINE COMPOUNDS

-

Paragraph 0729, (2013/09/26)

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound o f formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1289084-83-8